FNIP2 (folliculin interacting protein 2) is a key regulatory component of nutrient sensing and cellular metabolism that functions primarily as a binding partner of the tumor suppressor protein FLCN 1. FNIP2 regulates mTORC1 signaling through the non-canonical pathway by forming the FLCN-FNIP2 complex, which acts as a GTPase-activating protein (GAP) for RagC/D GTPases 2. Under amino acid-deficient conditions, FNIP2 promotes nuclear translocation of transcription factors TFEB and TFE3 by inhibiting mTORC1 activity, thereby activating autophagy and lysosomal biogenesis 3. The protein also functions as an HSP90 co-chaperone, inhibiting HSP90 ATPase activity and competing with activating co-chaperones to regulate client protein folding 1. FNIP2 can form homo- or heteromeric complexes with FNIP1, suggesting cooperative or independent functions 1. Disease relevance includes its role in Birt-Hogg-Dubé syndrome, where C-terminal FLCN mutations disrupt FNIP2 binding 1. Additionally, a polymorphism (rs2291007) in FNIP2's 3'UTR affects mRNA stability through miRNA regulation and correlates with human leanness and metabolic parameters 4. FNIP2 expression is differentially regulated in renal cell carcinomas and pancreatic cancers, where it supports tumor progression through mTORC1 activation 15.